Prolyl hydroxylase inhibitors and methods of use

摘要

The present disclosure relates to HIF-1αprolyl hydroxylase inhibitors, compositions which comprise the HIF-1αprolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.